How the Hep C Cure Works

Direct-acting antivirals (DAAs) are a new class of drugs that are used to treat hepatitis C. DAAs work by blocking the action of the hepatitis C virus (HCV), which prevents the virus from replicating and spreading.

There are several different types of DAAs, and they are typically used in combination with each other. The most common DAAs include:

* Boceprevir (Victrelis)

* Daclatasvir (Daklinza)

* Elbasvir (Zepatier)

* Faldaprevir (Incivek)

* Glecaprevir/pibrentasvir (Mavyret)

* Ledipasvir (Harvoni)

* Ombitasvir (Viekira Pak)

* Paritaprevir (Viekira Pak)

* Ravidasvir (Sovaldi)

* Sofosbuvir (Sovaldi)

* Simeprevir (Olysio)

* Telaprevir (Incivek)

* Vaniprevir (Vankirk)

DAAs are taken orally, once or twice a day. The length of treatment depends on the type of HCV genotype that a person has. Treatment typically lasts for 8 to 12 weeks.

DAAs are very effective in treating hepatitis C. In clinical trials, DAAs have been shown to cure hepatitis C in more than 90% of people. DAAs are also well-tolerated, with few side effects.

The cure for hepatitis C is a major breakthrough in the treatment of this disease. DAAs have made it possible for people with hepatitis C to live a normal, healthy life.